Back to top
more

The Chemours Company (CC)

(Delayed Data from NYSE)

$23.53 USD

23.53
1,755,490

-0.17 (-0.72%)

Updated Feb 26, 2021 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.41%
2Buy17.88%
3Hold9.48%
4Sell5.03%
5Strong Sell1.87%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (59 out of 253)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for CC More Info

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for The Chemours Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 1,105 943 1,201 1,556 902
Receivables 511 674 861 919 807
Notes Receivable 0 0 0 0 0
Inventories 939 1,079 1,147 935 767
Other Current Assets 78 81 84 83 77
Total Current Assets 2,633 2,777 3,293 3,493 2,553
Net Property & Equipment 3,474 3,559 3,291 3,008 2,784
Investments & Advances 167 162 160 173 136
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 167 174 181 166 170
Deposits & Other Assets 405 292 437 453 417
Total Assets 7,082 7,258 7,362 7,293 6,060
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 844 923 1,137 1,075 884
Current Portion Long-Term Debt 21 134 13 15 15
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 577 484 559 558 872
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 1,442 1,541 1,709 1,648 1,771
Mortgages 0 0 0 0 0
Deferred Taxes/Income 36 118 217 208 132
Convertible Debt 0 0 0 0 0
Long-Term Debt 4,005 4,026 3,959 4,097 3,529
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 590 633 457 475 524
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 6,267 6,563 6,342 6,428 5,956
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 890 859 860 837 789
Retained Earnings 1,303 1,249 1,466 579 -114
Other Equity -308 -343 -558 -437 -573
Treasury Stock 1,072 1,072 750 116 0
Total Shareholder's Equity 815 695 1,020 865 104
Total Liabilities & Shareholder's Equity 7,082 7,258 7,362 7,293 6,060
Total Common Equity 815 695 1,020 865 104
Shares Outstanding 164.50 163.50 171.00 185.10 181.80
Book Value Per Share 4.95 4.25 5.96 4.67 0.57

Fiscal Year End for The Chemours Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,105 956 1,031 714 943
Receivables 511 572 540 681 674
Notes Receivable 0 0 0 0 0
Inventories 939 993 1,074 1,114 1,079
Other Current Assets 78 84 72 82 81
Total Current Assets 2,633 2,605 2,717 2,591 2,777
Net Property & Equipment 3,474 3,418 3,423 3,444 3,559
Investments & Advances 167 182 175 167 162
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 167 169 171 172 174
Deposits & Other Assets 405 310 275 293 292
Total Assets 7,082 6,948 7,034 6,948 7,258
Liabilities & Shareholders Equity 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 844 701 651 841 923
Current Portion Long-Term Debt 21 32 19 22 134
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 577 575 486 480 484
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 1,442 1,308 1,156 1,343 1,541
Mortgages 0 0 0 0 0
Deferred Taxes/Income 36 34 58 88 118
Convertible Debt 0 0 0 0 0
Long-Term Debt 4,005 4,063 4,327 4,012 4,026
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 590 610 611 633
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 6,267 6,214 6,375 6,287 6,563
Shareholders Equity 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 890 879 872 870 859
Retained Earnings 1,303 1,325 1,290 1,308 1,249
Other Equity -308 -400 -433 -447 -343
Treasury Stock 1,072 1,072 1,072 1,072 1,072
Total Shareholder's Equity 815 734 659 661 695
Total Liabilities & Shareholder's Equity 7,082 6,948 7,034 6,948 7,258
Total Common Equity 815 734 659 661 695
Shares Outstanding 164.50 164.50 164.20 164.10 163.50
Book Value Per Share 4.95 4.46 4.01 4.03 4.25